Discover · sciam.com

Weighing the Good and Bad of Weight-Loss Drugs

60-Second Science sciam.com

This is what was read here when it was published. Scientific American no longer carries it in what it publishes now.

Drugs known as glucagon-like peptide-1 receptor agonists, colloquially called GLP-1 medications, have gone from relatively obscure diabetes treatments to blockbuster weight-loss medications. But is the hype backed up by science? In this episode, freelance science journalist Bethany Brookshire joins host Kendra Pierre-Louis to talk about how these drugs mimic natural hormones, why they’re so effective and what the latest research about their broader health effects says. Plus, we discuss what a recently rolled-out GLP-1 pill, the first of its kind approved for obesity, could mean for the future of weight loss.

Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means“Doctors Are Worried about Prescribing GLP-1s to Certain Patients,” by Bethany Brookshire, in National Geographic. Published online November 20, 2025

More ways to use this
Open on another device
Scan this QR code to open the same public page

Scan to open this page. Your saved notes and account access are not included.

Download QR code

Open the page link

Named in it

Keep going

Each of these is read from what this estate already kept: the feed a piece came through, the publisher behind it, the credits and topics the publisher printed. None of it is a recommendation, an identity or a record kept anywhere else.

Also from 60-Second Science

  1. The sopranos of the jungleScientific American sciam.com
  2. We started a book club. Naturally, we picked a book on fungiScientific American sciam.com
  3. Cover Story: The End of Math as We Know ItScientific American sciam.com
  4. A Roman-era frog whodunit and more science surprisesScientific American sciam.com
  5. Did I stutter?Scientific American sciam.com
  6. Could this be the strongest El Niño in 1,000 years?Scientific American sciam.com